CALX vs CIEN vs CSCO Stock Comparison

Calix, Ciena and Cisco Systems Prices as of Nov 13, 2026 Peers: Industry group
CALX Calix, Inc
$32.15 -10.8% 1M -46.7% 1Y
Market cap
$2.02B
P/E
44.2x
Revenue (TTM)
$1.15B
Div. yield
–
Networking Equipment Technology
2 wins
CIEN Ciena Corp
$280.61 -21.9% 1M +44.5% 1Y
Market cap
$36.60B
P/E
55.9x
Revenue (TTM)
$6.02B
Div. yield
–
Networking Equipment Technology
4 wins
CSCO Cisco Systems, Inc.
$95.64 -15.8% 1M +23.6% 1Y
Market cap
$374.07B
P/E
25.0x
Revenue (TTM)
$66.96B
Div. yield
–
Networking Equipment Technology
3 wins

Head to Head

9 decided of 12

Ciena leads on 4 of the 12 questions below (Ciena 4, Cisco Systems 3, Calix 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCALXCIENCSCOLeader
Larger companyMarket capitalisation $2.02B $36.60B $374.07B CSCO
Cheaper on earningsLower P/E, profitable companies only 44.2x 55.9x 25.0x CSCO
Cheaper on forward earningsLower price / next fiscal year consensus EPS 19.3x 36.9x 19.9x CALX
Faster revenue growthRevenue growth, trailing twelve months +22.9% +32.6% +16.1% CIEN
More profitableNet margin, trailing twelve months 4.0% 10.9% — CIEN
Better return on capitalReturn on invested capital — 12.4% — –
Less leveragedLower net debt / EBITDA — 0.7x — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -46.7% +44.5% +23.6% CIEN
Better 5-year returnAnnualised price return, 5 years -15.6%/yr +35.5%/yr +11.0%/yr CIEN
Less volatileAnnualised volatility, 1 year 41.9% 82.4% 37.3% CSCO
Higher overall scoreMean of the five percentile scores vs peers 72/100 56/100 45/100 CALX

Percentile Scorecard

CALXCIENCSCO

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCALXCIENCSCO
Valuation 57 #50 of 116 24 #89 of 116 29 #83 of 116
Growth 71 #33 of 110 93 #9 of 110 45 #61 of 110
Profitability 60 #44 of 108 80 #22 of 108 58 #46 of 108
Financial Health 73 #33 of 121 41 #72 of 121 18 #99 of 121
Shareholder Returns 100 #1 of 84 42 #49 of 84 76 #21 of 84
Overall 72 56 45
  • CALX ranked among 122 companies in Computer Hardware
  • CIEN ranked among 122 companies in Computer Hardware
  • CSCO ranked among 122 companies in Computer Hardware

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCALXCIENCSCOSPY
1 month -10.8%-21.9%-15.8% -2.0%
3 months -18.8%-34.6%-14.4% -2.8%
6 months -19.2%-49.4%-19.1% +2.0%
Year to date -39.3%+20.0%+24.2% +10.6%
1 year -46.7%+44.5%+23.6% +12.2%
3 years -14.7%+514.4%+79.9% +68.1%
3 years, per year -5.2%+83.2%+21.6% +18.9%
5 years -57.1%+356.9%+68.3% +61.4%
5 years, per year -15.6%+35.5%+11.0% +10.1%
10 years +317.5%+1,190.8%+205.0% +248.5%
10 years, per year +15.4%+29.2%+11.8% +13.3%

Risk

MeasureCALXCIENCSCOSPY
Volatility, 1Y 41.9%82.4%37.3% 13.6%
Downside volatility, 1Y 45.7%89.5%40.4% 13.9%
Beta vs S&P 500, 1Y 0.992.951.32 1.00
Return / volatility, 1Y -1.110.540.63 0.90
Max drawdown, 5Y -65.3%-63.2%-38.6% -25.4%
From 52-week high -46.7%-55.2%-26.4% -3.2%
52-week high $60.30$627.00$130.00 $779.14
52-week low $30.59$176.45$73.35 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCALXCIENCSCO
P/E now vs peer median 44.1xmedian 26.9x 60.9xmedian 26.9x 25.3xmedian 26.9x
P/S now vs peer median 1.7xmedian 2.2x 6.6xmedian 2.2x 5.6xmedian 2.2x
EV/EBITDA now vs peer median 23.5xmedian 15.5x 45.0xmedian 15.5x —median 15.5x
P/FCF now vs peer median 32.0xmedian 21.4x 48.9xmedian 21.4x 32.9xmedian 21.4x
P/B now vs peer median 2.8xmedian 2.4x 13.0xmedian 2.4x 7.3xmedian 2.4x
PEG now vs peer median 41.46median 1.03 1.36median 1.03 6.12median 1.03

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCALXCIENCSCO
Revenue $1.15B $6.02B $66.96B
Gross profit $637.49M $2.65B $42.90B
Operating income $60.39M $738.95M $17.60B
Net income $45.75M $654.41M $14.96B
Free cash flow $62.16M $814.36M –
R&D $215.00M $924.94M $9.59B
EPS (diluted) $0.71 $4.48 $3.75
Cash & equivalents $55.89M $2.45B $7.78B
Total debt – $3.23B –
Shares (diluted) 64.45M 145.97M 3.99B
Enterprise value $1.04B $30.16B $374.07B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCALXCIENCSCO
P/E 44.1x 60.9x 25.3x
P/FCF 32.0x 48.9x 32.9x
P/Operating cash flow 23.8x 37.8x 24.6x
P/S 1.7x 6.6x 5.6x
P/B 2.8x 13.0x 7.3x
P/Tangible book 2.8x 13.9x 8.5x
EV/EBITDA 23.5x 45.0x –
EV/EBIT 30.3x 54.7x –
EV/Revenue 1.6x 6.7x 5.6x
EV/FCF 29.5x 49.6x –
EV/Operating cash flow 21.9x 38.3x 24.6x
PEG (3Y EPS CAGR) 41.46 1.36 6.12

Growth

14 metrics
MetricCALXCIENCSCO
Revenue growth (1Y) 22.9% 32.6% 16.1%
Revenue CAGR (3Y) 4.0% 12.5% 4.9%
Gross profit growth (1Y) 21.6% 40.6% 14.7%
Gross profit CAGR (3Y) 6.4% 13.3% 5.1%
Operating income growth (1Y) 958.5% 200.1% 37.9%
Operating income CAGR (3Y) 6.0% 29.1% 3.7%
Net income growth (1Y) 730.9% 364.5% 44.8%
Net income CAGR (3Y) -1.5% 43.5% 3.3%
EPS growth (1Y) 783.2% 359.9% 45.0%
EPS CAGR (3Y) 1.1% 44.8% 4.1%
Operating cash flow growth (1Y) -19.9% 34.5% 11.5%
Operating cash flow CAGR (3Y) 20.7% 201.2% -5.7%
Free cash flow growth (1Y) -27.3% 34.5% –
Free cash flow CAGR (3Y) 29.3% 95.4% –

Profitability

14 metrics
MetricCALXCIENCSCO
Gross margin 55.6% 44.1% –
EBITDA margin 6.8% 14.9% –
Operating margin 5.3% 12.3% –
Pretax margin 6.1% 12.1% –
Net margin 4.0% 10.9% –
FCF margin 5.4% 13.5% –
Operating cash flow margin 7.3% 17.5% 22.9%
Return on equity 6.5% 22.0% 29.4%
Return on assets 4.9% 9.3% 11.5%
Return on invested capital – 12.4% –
Return on capital employed 8.0% 13.1% –
Asset turnover 1.2x 0.9x 0.5x
Cash conversion (OCF / net income) 1.8x 1.6x 1.0x
Stock comp / revenue 7.0% 3.5% 5.5%

Financial Health

11 metrics
MetricCALXCIENCSCO
Debt / assets – 40.4% –
Debt / equity – 1.1x –
Net debt / EBITDA – 0.7x –
Debt / FCF – 4.0x –
Liabilities / assets 24.1% 61.8% 60.1%
Equity / assets 75.9% 38.2% 39.9%
Interest coverage – 10.6x –
Current ratio 3.0x 3.8x 1.0x
Quick ratio 1.5x 2.8x –
Cash ratio 0.8x 1.9x –
Altman Z-score 6.85 6.03 –

Shareholder Returns

7 metrics
MetricCALXCIENCSCO
Dividend yield – – 1.7%
Net buyback yield 12.4% -1.2% –
Shareholder yield 12.4% -1.2% 1.7%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCALXCIENCSCO
Forward P/E 19.3xFY2026 36.9xFY2026 19.9xFY2027
EPS, next fiscal year $1.67FY2026 $7.60FY2026 $4.81FY2027
EPS growth, next FY +24.6%FY2026 +187.9%FY2026 +11.1%FY2027
EPS growth, the year after +52.7% +64.7% +20.4%
Revenue, next fiscal year $1.11BFY2026 $6.86BFY2026 $75.40BFY2027
Revenue growth, next FY +11.0%FY2026 +43.8%FY2026 +19.1%FY2027
Revenue growth, the year after +17.9% +18.0% +1.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCALXCIENCSCO
Held by institutions 94.5% 93.0% 80.1%
Institutions holding 290 1,224 4,051
Change in shares held, QoQ +0.5% -1.7% +5.0%
Institutions buying 148 733 1,850
Institutions selling 111 379 1,819
Buyers to sellers 1.33 1.93 1.02

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CALXCIENCSCO
CALX 1.00 0.24 0.27
CIEN 0.24 1.00 0.43
CSCO 0.27 0.43 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CALX, CIEN and CSCO?

Cisco Systems (CSCO) is the largest by market capitalisation: Calix (CALX) $2.02B, Ciena (CIEN) $36.60B, Cisco Systems (CSCO) $374.07B.

Which stock is cheaper, CALX, CIEN and CSCO?

Cisco Systems (CSCO) trades on the lowest price-to-earnings ratio (Calix (CALX) 44.2x, Ciena (CIEN) 55.9x, Cisco Systems (CSCO) 25.0x). On next year's consensus earnings, Calix (CALX) is cheapest (Calix (CALX) 19.3x, Ciena (CIEN) 36.9x, Cisco Systems (CSCO) 19.9x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Ciena (CIEN) grew revenue fastest over the trailing twelve months: Calix (CALX) +22.9%, Ciena (CIEN) +32.6%, Cisco Systems (CSCO) +16.1%.

Which company is more profitable?

Ciena (CIEN) has the highest net margin (Calix (CALX) 4.0%, Ciena (CIEN) 10.9%).

Which stock has performed better?

Over the past year Ciena (CIEN) returned the most: Calix (CALX) -46.7%, Ciena (CIEN) +44.5%, Cisco Systems (CSCO) +23.6%. Over five years, Ciena (CIEN) compounded fastest (Calix (CALX) -15.6%/yr, Ciena (CIEN) +35.5%/yr, Cisco Systems (CSCO) +11.0%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Cisco Systems (CSCO) has been the steadiest (Calix (CALX) 41.9%, Ciena (CIEN) 82.4%, Cisco Systems (CSCO) 37.3%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CALX, CIEN and CSCO?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Ciena (CIEN) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.